Literature DB >> 31576337

New promising circulating RNA biomarkers for early diagnosis of lung adenocarcinoma.

Francisco J Enguita1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31576337      PMCID： PMC6685864          DOI： 10.21037/atm.2019.05.70

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  18 in total

Review 1.  Intriguing circles: Conflicts and controversies in circular RNA research.

Authors:  Hui-Min Li; Xiu-Lan Ma; Hong-Gang Li
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-04-29       Impact factor: 9.957

Review 2.  Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology.

Authors:  Christina Alidousty; Till Baar; Carina Heydt; Svenja Wagener-Ryczek; Anna Kron; Juergen Wolf; Reinhard Buettner; Anne Maria Schultheis
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

3.  Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction.

Authors:  Nobuyuki Watanabe; Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Takuma Ohashi; Wataru Okajima; Toshiyuki Kosuga; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Hitoshi Tsuda; Eigo Otsuji
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

4.  The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma.

Authors:  Mantang Qiu; Wenjia Xia; Rui Chen; Siwei Wang; Youtao Xu; Zhifei Ma; Weizhang Xu; Erbao Zhang; Jie Wang; Tian Fang; Jingwen Hu; Gaochao Dong; Rong Yin; Jun Wang; Lin Xu
Journal:  Cancer Res       Date:  2018-03-27       Impact factor: 12.701

Review 5.  Circular RNAs as Biomarkers for Cancer.

Authors:  Lu Xia; Meiyi Song; Mengxue Sun; Fei Wang; Changqing Yang
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 6.  Circular RNAs in Cancer.

Authors:  Susanne Lux; Lars Bullinger
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

7.  A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.

Authors:  Xiao-Xia Liu; Yi-E Yang; Xiao Liu; Meng-Yu Zhang; Rui Li; Yun-Hong Yin; Yi-Qing Qu
Journal:  J Transl Med       Date:  2019-02-18       Impact factor: 5.531

8.  Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma.

Authors:  Yali Wu; Xiaolei Zhang; Yongzhen Liu; Fengmin Lu; Xiangmei Chen
Journal:  Int J Mol Sci       Date:  2016-01-25       Impact factor: 5.923

Review 9.  Circular RNAs: clinical relevance in cancer.

Authors:  Zhijie Xu; Yuanliang Yan; Shuangshuang Zeng; Shuang Dai; Xi Chen; Jie Wei; Zhicheng Gong
Journal:  Oncotarget       Date:  2017-12-01

Review 10.  Identifying and Characterizing circRNA-Protein Interaction.

Authors:  William W Du; Chao Zhang; Weining Yang; Tianqiao Yong; Faryal Mehwish Awan; Burton B Yang
Journal:  Theranostics       Date:  2017-09-26       Impact factor: 11.556
View more
  2 in total

Review 1.  cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?

Authors:  Tomasz Kolenda; Kacper Guglas; Dawid Baranowski; Joanna Sobocińska; Magda Kopczyńska; Anna Teresiak; Renata Bliźniak; Katarzyna Lamperska
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-11

Review 2.  Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights.

Authors:  Hamed Hosseinalizadeh; Mehrdad Mahmoodpour; Ammar Ebrahimi
Journal:  Mol Biol Rep       Date:  2021-10-22       Impact factor: 2.316
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.